Conference Description:

Fulfil data's promise: achieve greater access

The promise of data has arrived: time for authenticity, credibility and empowerment.

Data already dictates payer decisions. It already provides a new guiding light for pharma companies. But now, it's time for data to do even more - achieve access, change the nature of our customer relationships and reinvigorate our reputation.

As we focus on more focussed and specialist pipelines, as we develop true expertise and recognition around key therapies, as we operate in a more intensive way, we need to be able to create and demonstrate value.

This is the conference where expectations meet reality. Join the leading thought leaders, key stakeholder and biggest industry case studies from across the continent at eyeforpharma Real-World Evidence and Access Europe Summit 2018 (April, 24-25).

Key speakers include:
Steve Wooding, VP, Head, Global Commercial and Market Access Strategy Organisation, Janssen

Gillian Leng, Deputy Chief Executive, NICE

Isabel Torres, VP Market Access, Public Affairs and Patient Advocacy for Europe and Canada, Takeda

Nigel Hughes, Scientific Director, Janssen

Sajan Khosla, Head of Real World Evidence - Centre of Excellence, Medical Evidence and Observational Research, AstraZeneca

Time: 09:00 to 16:00

Price:
Pharma Gold Pass: EUR 1899,
Pharma Silver: EUR 1599,
Pharma Diamond: EUR 2899

Speakers: Gillian Leng, Steve Wooding, Isabel Torres, Pernille Storm, Martin Gibson, Enkeleida Nikai-Fitzgerald, Bart Vanniewenhuyse, Sajan Khosla